Adaptation and Antituberculosis Drug-induced Liver Injury

被引:3
|
作者
Devarbhavi, Harshad [1 ]
机构
[1] St Johns Med Coll Hosp, Bangalore, Karnataka, India
关键词
ISONIAZID PREVENTIVE THERAPY; FUNCTION TESTS; HEPATOTOXICITY;
D O I
10.1164/ajrccm.186.4.387
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:387 / 388
页数:2
相关论文
共 50 条
  • [1] Adaptation and Antituberculosis Drug-induced Liver Injury Reply
    Singanayagam, Aran
    Burroughs, Andrew K.
    Kon, Onn Min
    Wickremasinghe, Melissa
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (04) : 388 - 389
  • [2] Antituberculosis Therapy Drug-Induced Liver Injury and Acute Liver Failure
    Devarbhavi, Harshad
    Dierkhising, Ross
    Kremers, Walter K.
    HEPATOLOGY, 2010, 52 (02) : 798 - 799
  • [4] Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis
    Park, Wan Beom
    Kim, Won
    Lee, Kook Lae
    Yim, Jae-Joon
    Kim, Moonsuk
    Jung, Yong Jin
    Kim, Nam Joong
    Kim, Dong Hee
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Oh, Myoung-don
    Lee, Hyo Suk
    JOURNAL OF INFECTION, 2010, 61 (04) : 323 - 329
  • [5] Antituberculosis Therapy Drug-Induced Liver Injury and Acute Liver Failure Reply
    Acharya, Subrat Kumar
    HEPATOLOGY, 2010, 52 (02) : 799 - 800
  • [6] The role of regular liver function monitoring in antituberculosis drug-induced liver injury
    Chang, Tien-En
    Huang, Yi-Shin
    Su, Wei-Juin
    Perng, Chin-Lin
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (07) : 535 - 540
  • [7] Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury
    Liu, Quanxian
    Huang, Lu
    Yan, Hong
    Zong, Zhaojing
    Chen, Zhenyong
    Wu, Xiaoyan
    Chen, Ling
    Lan, Yuanbo
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [8] Recent progress in genetic variation and risk of antituberculosis drug-induced liver injury
    Huang, Yi-Shin
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2014, 77 (04) : 169 - 173
  • [9] Mitochondrial DNA content as a diagnostic marker for antituberculosis drug-induced liver injury
    Udomsinprasert, Wanvisa
    Jittikoon, Jiraphun
    Chaikledkaew, Usa
    Saengsiwaritt, Wacharapol
    Chanhom, Noppadol
    Suvichapanich, Supharat
    Wattanapokayakit, Sukanya
    Mahasirimongkol, Surakameth
    Chantratita, Wasun
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 1034 - 1040
  • [10] Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury
    Huang, Yi-Shin
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (01) : 1 - 8